Carnitine Palmitoyltransferase Deficiency: Diagnosis & Treatment

Written by Medicover Team and Medically Reviewed by Dr Neha Mukhi , Pediatricians

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Carnitine Palmitoyltransferase (CPT) Deficiency is a rare inherited metabolic disorder that affects the body's ability to break down long-chain fatty acids for energy. It is caused by mutations in the CPT1A, CPT2, or SLC25A20 genes, depending on the specific type of the disorder. Symptoms may include muscle pain, weakness, recurrent episodes of muscle breakdown (rhabdomyolysis), low blood sugar, liver problems, and heart complications in severe cases. Symptoms are often triggered by prolonged fasting, illness, strenuous exercise, or cold exposure. Early diagnosis, dietary management, and avoiding known triggers can help prevent metabolic crises and improve long-term outcomes.

What are the Types of Carnitine Palmitoyltransferase Deficiency?

CPT I Deficiency: This type is less common and is caused by mutations in the CPT1A gene. It primarily affects the liver, leading to symptoms such as hypoketotic hypoglycemia, liver dysfunction, and an increased risk of life-threatening complications during fasting or illness.
CPT II Deficiency: The more prevalent form, CPT II deficiency, is caused by mutations in the CPT2 gene. It typically manifests in three forms: lethal neonatal, severe infantile hepatic cardiovascular, and the myopathic form, which is the most common and occurs during adolescence or adulthood. The symptoms include muscle pain, weakness, and episodes of rhabdomyolysis triggered by prolonged exercise, fasting, or illness.

What are the Symptoms of Carnitine Palmitoyltransferase Deficiency?

The symptoms of CPT deficiency can vary widely depending on the type and severity of the condition. They may also differ from one individual to another. Recognizing these symptoms is crucial for early diagnosis and management.

Common Symptoms

Hypoketotic Hypoglycemia: This is a hallmark symptom of CPT deficiency, characterized by low blood sugar levels without the expected increase in ketones, which are typically produced when the body burns fat for energy.
Muscle Weakness and Pain: Muscle-related symptoms are particularly prominent in CPT II deficiency. Individuals may experience muscle pain, stiffness, and weakness, especially after prolonged physical activity or fasting.
Rhabdomyolysis: Episodes of rhabdomyolysis, a condition involving the breakdown of muscle tissue, can occur, leading to muscle pain, swelling, and potential kidney damage if not treated promptly.
Liver Dysfunction: In severe cases, particularly with CPT I deficiency, liver dysfunction can occur, presenting as hepatomegaly (enlarged liver), jaundice, and elevated liver enzymes.
Cardiomyopathy: Some individuals with CPT deficiency may develop heart-related symptoms, such as an enlarged heart (cardiomegaly) and heart failure, particularly in the severe infantile form of CPT II deficiency.
Encephalopathy: Neurological symptoms, including encephalopathy (brain dysfunction), may occur in severe cases, leading to confusion, seizures, or coma.

What are the Causes of Carnitine Palmitoyltransferase Deficiency?

Carnitine Palmitoyltransferase (CPT) Deficiency is caused by inherited genetic mutations that affect the body's ability to break down long-chain fatty acids for energy. The specific cause depends on the type of CPT deficiency.

Here are the cause:

Inherited genetic mutations passed down in an autosomal recessive pattern.
Mutations in the CPT1A gene, causing CPT I deficiency.
Mutations in the CPT2 gene, causing CPT II deficiency.
Defects in fatty acid oxidation, preventing the body from using long-chain fatty acids as an energy source.
Both parents carrying a mutated gene, increasing the risk of the condition in their child.
Family history of Carnitine Palmitoyltransferase Deficiency or other inherited metabolic disorders.

When to See a Doctor for Carnitine Palmitoyltransferase (CPT) Deficiency?

Seek medical attention if you or your child:

Experience recurrent muscle pain, weakness, or exercise intolerance.
Develop dark-colored urine, which may indicate muscle breakdown (rhabdomyolysis).
Have episodes of low blood sugar (hypoglycemia), excessive sleepiness, or seizures.
Experience symptoms after prolonged fasting, illness, strenuous exercise, or cold exposure.
Have a family history of CPT deficiency or another inherited metabolic disorder and develop similar symptoms.

High-risk groups:

Newborns and infants with abnormal newborn screening results
Children and adults with recurrent rhabdomyolysis or unexplained muscle weakness
Individuals with a family history of fatty acid oxidation disorders
People with a known CPT1A or CPT2 gene mutation

Do not ignore persistent or recurring symptoms. Consult a Pediatrician for early diagnosis and treatment can help prevent metabolic crises and improve long-term outcomes.

Find Pediatricians for Carnitine Palmitoyltransferase Deficiency Treatment Near You

How is Carnitine Palmitoyltransferase Deficiency Diagnosed?

Diagnosing CPT deficiency involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Early diagnosis is essential for effective management and prevention of complications.

Clinical Evaluation

A thorough clinical assessment is crucial, with a focus on the patient's medical history, family history, and presenting symptoms. Physicians may look for signs of hypoglycemia, muscle pain, and liver dysfunction.

Laboratory Tests

Blood Tests: Blood tests may reveal low blood sugar levels, elevated liver enzymes, and abnormal levels of creatine kinase (CK), which is indicative of muscle damage.
Urine Tests: Urine tests can detect the presence of myoglobin, a protein released during muscle breakdown, which is a marker of rhabdomyolysis.
Fatty Acid Oxidation Studies: Specialized tests to assess the body's ability to metabolize fats can help confirm the diagnosis of CPT deficiency.

Genetic Testing

Genetic testing is a definitive method for diagnosing CPT deficiency. It involves analyzing the CPT1A, CPT2, or SLC25A20 genes for mutations. Identifying the specific genetic mutation can aid in determining the type of CPT deficiency and guide treatment decisions.

What are the Treatment Options for Carnitine Palmitoyltransferase Deficiency?

Managing CPT deficiency involves a combination of dietary modifications, lifestyle adjustments, and medical interventions to prevent symptoms and complications.

Dietary Modifications

High-Carbohydrate, Low-Fat Diet: Individuals with CPT deficiency are often advised to follow a diet that is high in carbohydrates and low in long-chain fats to minimize the reliance on fat oxidation for energy.
Frequent Meals: Regular, frequent meals can help maintain stable blood sugar levels and prevent fasting-induced symptoms.
Medium-Chain Triglycerides (MCTs): MCTs can be included in the diet as they are more easily metabolized and do not require the CPT pathway for energy production.

Lifestyle Adjustments

Avoiding Prolonged Fasting and Intense Exercise: To prevent episodes of hypoglycemia and rhabdomyolysis, individuals with CPT deficiency should avoid prolonged fasting and engage in moderate physical activity.
Monitoring for Symptoms: Regular monitoring for symptoms of hypoglycemia, muscle pain, and liver dysfunction is essential for timely intervention.

Medical Interventions

Supplementation: Carnitine supplementation may be recommended to support fat metabolism and reduce muscle symptoms.
Emergency Treatment: In cases of acute episodes, prompt medical attention is necessary. Treatment may include intravenous glucose to address hypoglycemia and hydration to prevent kidney damage from rhabdomyolysis.

Your health is everything - prioritize your well-being today.

Consult Carnitine Palmitoyltransferase Deficiency Doctors Today

Frequently Asked Questions

1. What are the symptoms of Carnitine Palmitoyltransferase Deficiency?

Symptoms may include muscle weakness, hypoglycemia, and cardiomyopathy, often presenting during infancy or childhood with episodes of metabolic crises.

2. What causes Carnitine Palmitoyltransferase Deficiency?

Carnitine palmitoyltransferase deficiency is caused by genetic mutations affecting fatty acid metabolism, leading to impaired energy production from fats during periods of fasting or illness.

3. How is Carnitine Palmitoyltransferase Deficiency diagnosed?

Diagnosis typically involves clinical evaluation, blood tests to assess carnitine levels, and genetic testing to confirm associated mutations.

4. What are the treatment options for Carnitine Palmitoyltransferase Deficiency?

Treatment may include dietary management to provide sufficient carbohydrates, carnitine supplementation, and careful monitoring during illness or fasting.